-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
The relationship between adipokines, body composition, and bone density in men with chronic obstructive pulmonary disease
Original Research
(2668) Views (829) Full article downloads
Authors: Sheryl F Vondracek, Norbert F Voelkel, Michael T McDermott, Connie Valdez
Published Date July 2009
Volume 2009:4 Pages 267 - 277
DOI: http://dx.doi.org/10.2147/COPD.S2745
Sheryl F Vondracek1, Norbert F Voelkel2, Michael T McDermott3, Connie Valdez1
1Department of Clinical Pharmacy; 3Department of Medicine, University of Colorado Denver, Aurora, CO, USA; 2Department of Internal Medicine and Victoria Johnson Center for Emphysema Research, Virginia Commonwealth University, Richmond, VA, USA
Abstract: Osteoporosis is common in patients with chronic obstructive pulmonary disease (COPD). Data regarding the relationship between adipokines and bone mineral density (BMD) in this population is lacking. The purpose of this pilot study was to determine associations between the adipokines tumor necrosis factor-alpha (TNF-α), leptin, adiponectin and resistin, body composition, and BMD in men with severe COPD. This was a cross-sectional study of men with severe COPD who visited the University of Colorado Hospital COPD Center. Bone density and parameters of body composition were measured by dual-energy X-ray absorptiometry. Twenty-three men were included (mean age = 66 years, mean percent predicted forced expiratory volume in one second = 32%). On bivariate analysis, there was no association between TNF-α and BMD. Parameters of body composition and serum concentrations of leptin and adiponectin were significantly associated with total hip and spine bone density. However, with partial correlation analysis, total body mass was the only independent predictor of total hip BMD, explaining approximately 50% of the variability. Overall, 18 out of 23 men enrolled (78%) had low bone density by T-score, and nine (39%) were classified as having osteoporosis. The men with osteoporosis had lower parameters of body composition, lower mean serum leptin concentrations, and a greater impairment in measures of lung function compared to the men without osteoporosis. We conclude that the effect of adipokines on BMD does not appear to be independent of body mass. However, larger studies are needed to further evaluate the relationship between adipokines, body weight, and BMD in patients with COPD.
Keywords: bone mineral density, osteoporosis, TNF-α, leptin, adiponectin, chronic obstructive pulmonary disease, adipokines
Other articles by Dr Sheryl Vondracek
Readers of this article also read:
Preferential recruitment of neutrophils by endothelin-1 in acute lung inflammation induced by lipopolysaccharide or cigarette smoke
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Effects of pulmonary rehabilitation on exercise capacity in patients with COPD: A number needed to treat study
Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
Long-term therapy in COPD: any evidence of adverse effect on bone?
The pathophysiology of bronchiectasis
Development and implementation of treadmill exercise testing protocols in COPD
In search of parsimony: reliability and validity of the Functional Performance Inventory-Short Form
COSEHC global vascular risk management quality improvement program: rationale and design
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




